Mixed Dementias: Clinical Trials

2 trials for Mixed Dementias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Active not recruiting 1, Completed 1

Follow Mixed Dementias: new trials by email Literature Review of Mixed Dementias trials Research Report on Mixed Dementias

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy
Atorvastatin 40 Mg Oral Tablet, Placebo - Dementia, Mixed, Dementia, Vascular
Phase 4Active not recruitingMonash University3412019-09-192025-05-22
The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life
Galantamine, Nimodipine, Placebo - Dementia
Phase 4CompletedJanssen-Cilag Farmaceutica Ltda.222008-06-012013-08-26

Narrower conditions

Cognitive Dysfunction (1)  ·  Dementia (1)  ·  Dementia, Vascular (1)

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Mental Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurocognitive Disorders (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Cognition Disorders (1)  ·  Dementia (1)  ·  Intracranial Arterial Diseases (1)  ·  Intracranial Arteriosclerosis (1)  ·  Leukoencephalopathies (1)  ·  Vascular Diseases (1)

Interventions

Atorvastatin (1)  ·  Galantamine (1)  ·  Nimodipine (1)  ·  Tablets (1)

Sponsors

Janssen-Cilag Farmaceutica Ltda. (1)  ·  Monash University (1)

Countries

Australia (1)

Top investigators

Sophia Zoungas, MBBS, FRACP (1)

Results publications

PMID 24964105, PMID 37920607